Novel Combination Cancer Immunotherapy Summit 2024

Temas de la conferencia
Welcome to the Novel Combination Cancer Immunotherapy Summit - Supercharging Immunotherapies with Rational Combinations of ICIS, OVs, Adoptive Cells and Beyond

Organizador profesional (PCO)
Hanson Wade Group

Observaciones
URL:
Brochure: https://go.evvnt.com/2511263-2?pid=4832

Speakers: Michael Chisamore, Executive Director, Clinical Research, Merck and Co, Raj Ganesan, Executive Director, Oncology, Amgen , Yuanming Xu, Associate Director, Pfizer, and more

https://go.evvnt.com/2511263-1?pid=4832

Ms. Nell Sydenham